New growth hormone treatment for short children enters final testing phase
NCT ID NCT07553351
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new growth hormone injection (GB06) in 192 children aged 3 to 11 with growth hormone deficiency, a condition that causes slow growth. The treatment is given daily for 52 weeks to see if it helps children grow taller at a similar rate to an existing approved hormone. The goal is to offer a safe and effective alternative for managing this condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROWTH HORMONE DEFICIENCY (GHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chengdu Women and Children Central Hospital
RECRUITINGChengdu, Sichuan, 610074, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a weekly shot replace daily growth hormone for kids?
- Daily pill may replace growth hormone shots for children
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- Weekly shot could replace daily growth hormone injections for children
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- New growth hormone drug sogroya® tracked in kids for up to 3 years